RxDoctor Payments Data

Ludmil Mitrev

Anesthesiology · Camden, NJNPI 1508852153

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $862 of the $1,262 with a category attached, or 68.3%. Edwards Lifesciences accounts for 63.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $920 and has fallen 86.2% since, to $127 in 2025. Among anesthesiology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,262in general payments, 2019–2025

Across 17 payments — averaging $74.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$795
  • Covidien LP$133
  • Octapharma USA, Inc.$127
  • Vertex$106
  • Merck$64
  • Acacia Pharma Inc$20
  • plus $16 from 1 others
$94,241in research payments, 2019–2025

Across 15 payments — averaging $6282.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Baxter Healthcare$71K
  • Masimo Corporation$23K

What the payments were for

  • Speaking & faculty fees$40032%
  • Food & beverage$86268%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,262 in reported general payments places this provider in the 90th percentile of 1,430 anesthesiology providers in New Jersey.

See all anesthesiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$48,078
Medicare patients
153
Services billed
211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Camden

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →